JP2024534111A5 - - Google Patents

Info

Publication number
JP2024534111A5
JP2024534111A5 JP2024510689A JP2024510689A JP2024534111A5 JP 2024534111 A5 JP2024534111 A5 JP 2024534111A5 JP 2024510689 A JP2024510689 A JP 2024510689A JP 2024510689 A JP2024510689 A JP 2024510689A JP 2024534111 A5 JP2024534111 A5 JP 2024534111A5
Authority
JP
Japan
Prior art keywords
group
groups
alkyl
halogenated
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024510689A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024534111A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2022/115068 external-priority patent/WO2023025277A1/zh
Publication of JP2024534111A publication Critical patent/JP2024534111A/ja
Publication of JP2024534111A5 publication Critical patent/JP2024534111A5/ja
Pending legal-status Critical Current

Links

JP2024510689A 2021-08-26 2022-08-26 芳香環系を含有する生物アンタゴニスト、その製造方法及び応用 Pending JP2024534111A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN202110988568.9 2021-08-26
CN202110988568 2021-08-26
CN202210633028.3 2022-06-06
CN202210633028 2022-06-06
PCT/CN2022/115068 WO2023025277A1 (zh) 2021-08-26 2022-08-26 含芳环类生物拮抗剂、其制备方法和应用

Publications (2)

Publication Number Publication Date
JP2024534111A JP2024534111A (ja) 2024-09-18
JP2024534111A5 true JP2024534111A5 (OSRAM) 2025-07-18

Family

ID=85322470

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024510689A Pending JP2024534111A (ja) 2021-08-26 2022-08-26 芳香環系を含有する生物アンタゴニスト、その製造方法及び応用

Country Status (10)

Country Link
US (1) US20240368123A1 (OSRAM)
EP (1) EP4393920A4 (OSRAM)
JP (1) JP2024534111A (OSRAM)
KR (1) KR20240051999A (OSRAM)
CN (1) CN117836294A (OSRAM)
AU (1) AU2022334402A1 (OSRAM)
CA (1) CA3229397A1 (OSRAM)
MX (1) MX2024002411A (OSRAM)
TW (1) TW202328116A (OSRAM)
WO (1) WO2023025277A1 (OSRAM)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7735563B2 (ja) * 2021-10-21 2025-09-08 ニコヤ セラピューティクス(シャンハイ)カンパニー リミテッド 二重アンタゴニスト及びその使用
WO2025094214A1 (en) * 2023-11-02 2025-05-08 Msn Laboratories Private Limited, R&D Center Process for the preparation of 2-[4-[(2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-2-(ethoxymethyl)phenyl]-N-(4,5-dimethyl-1,2-oxazol-3-yl) benzenesulfonamide and its intermediates thereof
IT202400000246A1 (it) * 2024-01-09 2025-07-09 Procos Spa Processo per la preparazione di sparsentan
WO2026021516A1 (zh) * 2024-07-25 2026-01-29 深圳信立泰药业股份有限公司 一种取代的血管紧张肽和内皮肽受体拮抗剂及其应用
WO2026067819A1 (zh) * 2024-09-30 2026-04-02 江苏豪森药业集团有限公司 含芳环类生物拮抗剂在制备治疗或预防肾脏疾病药物中的应用
CN119462631A (zh) * 2024-10-09 2025-02-18 广东莱佛士制药技术有限公司 一种司巴生坦中间体的合成方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06510763A (ja) * 1991-08-19 1994-12-01 イー・アイ・デュポン・ドゥ・ヌムール・アンド・カンパニー アンジオテンシン2受容体遮断イミダゾリノン誘導体
US6638937B2 (en) * 1998-07-06 2003-10-28 Bristol-Myers Squibb Co. Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
PT1094816E (pt) * 1998-07-06 2009-03-10 Bristol Myers Squibb Co Sulfonamidas bifenílicas duplamente antagonistas receptores de angiotensina e endotelina
EP1741713A3 (en) * 1999-12-15 2009-09-09 Bristol-Myers Squibb Company Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
ES2259909B1 (es) * 2005-02-28 2007-06-16 Inke, S.A. Procedimiento para la obtencion de un compuesto farmaceuticamente activo y de su intermedio de sintesis.
BRPI0708507A2 (pt) * 2006-03-03 2011-05-31 Torrent Pharmaceuticals Ltd Novos antagonistas de receptores de dupla ação (dara) para os receptores at1 eta
WO2007109456A2 (en) * 2006-03-16 2007-09-27 Pharmacopeia, Inc. Substituted biphenyl isoxazole sulfonamides as dual angiotensin endothelin receptor antagonists
ES2302671T1 (es) * 2006-08-29 2008-08-01 Teva Pharmaceutical Industries Ltd. Procedimientos para la sintesis de 5-fenil-1-tritil-1h-tetrazol.
JP2011518884A (ja) * 2008-04-29 2011-06-30 セラヴァンス, インコーポレーテッド 二重活性抗高血圧剤
DK3222277T3 (da) 2009-03-31 2020-05-11 Ligand Pharm Inc Biphenylsulfonamidendothelin- og angiotensin II-receptorantagonist til behandling af glomerulosklerose og IgA-induceret nefropati
WO2010135350A2 (en) * 2009-05-20 2010-11-25 Pharmacopeia, Llc Biphenyl intermediate compounds and methods for the preparation of a dual angiotensin ii and endothelin a receptor antagonist
CN104761548B (zh) * 2015-04-27 2017-09-12 梯尔希(南京)药物研发有限公司 一种稳定同位素标记的二苯基磺酰胺类药物的制备方法
WO2018005591A1 (en) * 2016-06-29 2018-01-04 Universite De Montreal Biarylmethyl heterocycles
MA46524A (fr) 2016-10-13 2019-08-21 Retrophin Inc Composés de biphényl-sulfonamide destinés au traitement de néphropathies
CN112876424B (zh) * 2019-11-29 2023-06-30 上海拓界生物医药科技有限公司 血管紧张素ii受体及内皮素受体双重拮抗剂
JP7735563B2 (ja) * 2021-10-21 2025-09-08 ニコヤ セラピューティクス(シャンハイ)カンパニー リミテッド 二重アンタゴニスト及びその使用
JP2024178482A (ja) * 2021-11-15 2024-12-25 株式会社アークメディスン 化合物、アンジオテンシンiiタイプ1受容体拮抗剤及び医薬組成物

Similar Documents

Publication Publication Date Title
ES2715458T3 (es) Inhibidores de dihidropirrolopiridina de ROR-gamma
ES2977683T3 (es) Derivados de bencimidazolona y análogos de los mismos, como moduladores de IL-17
ES2750655T3 (es) Derivados de pirrolo[2,3-d]pirimidina útiles para inhibir la Janus cinasa
US9175013B2 (en) Fused aminodihydrothiazine derivatives
US8592408B2 (en) Fused aminodihydrothiazine derivatives
US9840532B2 (en) 5′-substituted nucleoside compounds
ES2689526T3 (es) Moduladores de P2X7
ES2714048T3 (es) Moduladores de P2X7
RU2011147200A (ru) Азетидинилдиамиды в качестве ингибиторов моноациглицерин-липазы
TW202227389A (zh) 新穎化合物
JP2019532052A5 (OSRAM)
CA2680157A1 (en) Novel 2-heteroaryl substituted benzothiophenes and benzofuranes 709
JP6775009B2 (ja) 3−ビシクロ[3.2.0]ヘプ−3−エン−6オンエンの鏡像異性体の分離
CN109790116A (zh) Trpv4拮抗剂
PE20201151A1 (es) Moduladores alostericos positivos del receptor de dopamina d1
JP5437525B1 (ja) チロシン誘導体およびチロシン誘導体の製造方法
JP2004525972A5 (OSRAM)
ES2650139T3 (es) Compuestos 3-fenilsulfanilmetil-biciclo[3.1.0]hexano 4-sustituidos como antagonistas de mGluR 2/3
CN117964637A (zh) 一种新型肽基腈类化合物及其应用
WO2012171248A1 (zh) 1,3-噁唑烷-2-酮类化合物、其制备方法和用途
JP2018140987A5 (OSRAM)
WO2014015125A1 (en) Fused aminodihydrothiazine derivative salts and uses thereof
JP6723250B2 (ja) N−[3−[(4ar,7as)−2−アミノ−6−(5−フルオロピリミジン−2−イル)−4,4a,5,7−テトラヒドロピロロ[3,4−d][1,3]チアジン−7a−イル]−4−フルオロ−フェニル]−5−メトキシ−ピラジン−2−カルボキサミドのトシル酸塩
WO2024088307A1 (zh) 一种新型肽基腈类化合物及其应用
US9828390B2 (en) Tetrahydropyrrolo[3,4-D][1,3]thiazine-derivative as BACE inhibitor